The BEL 20 gained 1.21% and finished among Europe’s strongest national indices, supported by UCB and AB InBev. Elsewhere, mining and industrial shares advanced, while banks and pharmaceutical heavyweight Novo Nordisk came under pressure.
BRUSSELS, August 5, 2026 — European stock markets ended Wednesday’s session without a common direction as investors balanced encouraging corporate earnings against renewed uncertainty surrounding the Middle East and oil supplies.
Brussels was a notable outperformer. The BEL 20 closed at 5,775.95 points, up 68.81 points or 1.21%, after reaching an intraday high of 5,796.20. The Belgian benchmark moved back towards its July record of 5,817.71 points and extended its gain over the past twelve months to approximately 24%.
The broader European market remained close to record territory, although performance varied significantly between countries and sectors. Corporate results supported miners, industrial companies and selected healthcare stocks, while banks and several large pharmaceutical shares declined.
European closing snapshot
| Index | Closing level | Daily change |
|---|---|---|
| BEL 20 | 5,775.95 | +1.21% |
| CAC 40 | 8,669.30 | +0.03% |
| DAX | 26,139.03 | −0.24% |
| FTSE 100 | 10,888.30 | +0.08% |
| IBEX 35 | 20,057.00 | +0.17% |
| FTSE MIB | 53,446.80 | −0.18% |
| AEX | 1,111.34 | −0.10% |
| Euro Stoxx 50 | 6,480.25 | −0.10% |
Closing levels are based on the latest available market data for August 5. Global index data
BEL 20 closes sharply higher
Brussels recorded one of Europe’s strongest performances of the session. The BEL 20 advanced from its previous close of 5,707.14 points and traded within approximately 0.7% of its recent all-time high.
UCB was among the most prominent Belgian gainers, advancing 2.60% to €229.10. The pharmaceutical group recovered part of its recent decline, although the shares remained almost 9% lower over five sessions and approximately 4% below their level at the beginning of the year.
Trading volume in UCB was relatively light, at about 69,500 shares compared with a 65-day average of approximately 231,000. The move therefore reflected a price recovery without an exceptional increase in turnover. MarketWatch
AB InBev gained approximately 0.7%, helping the capitalisation-weighted Belgian index. The brewer remained in focus after E.P.S., a holding company representing legacy shareholders, announced plans to sell about 10 million AB InBev shares.
The proposed placement was worth approximately €752 million based on the brewer’s closing price before the announcement. E.P.S. held more than 67 million shares, representing around 3.75% of AB InBev’s outstanding capital. Reuters
Large Belgian financial and healthcare companies also contributed to the index’s relative strength. Because AB InBev, KBC, UCB, Argenx and Ageas represent a substantial part of the BEL 20, movements in these shares can have an outsized effect on the benchmark.
European markets struggle for direction
The pan-European Stoxx 600 briefly established another intraday record before losing momentum. Investors were encouraged by several better-than-expected earnings reports but remained cautious as geopolitical headlines pushed oil prices higher.
Germany’s DAX declined 0.24%, despite positive reactions to selected industrial results. France’s CAC 40 was almost unchanged, while weakness in luxury shares limited gains from Carrefour, Legrand and other domestic companies.
London’s FTSE 100 added 0.08%. Mining shares provided support, but the index finished well below its session high. Madrid’s IBEX 35 rose 0.17%, while Milan’s FTSE MIB slipped 0.18%.
The AEX declined 0.10% in Amsterdam, even as Heineken attracted buying interest. The Euro Stoxx 50, comprising the eurozone’s largest companies, finished approximately 0.10% lower.
Sandoz leads the corporate gainers
Corporate earnings remained the most important driver of individual share-price movements.
Sandoz jumped 7.4%, making the Swiss generic-drug producer one of the Stoxx 600’s strongest performers. Second-quarter net sales rose 9%, supported by growing demand for biosimilar medicines as patents expire on major pharmaceutical products.
Glencore gained 3.3% after reporting an 86% increase in first-half earnings, beating market expectations. The result helped lift the basic-resources sector as gold climbed to its highest level in approximately one month.
Mining shares collectively gained around 1.4% during the session, making the sector one of Europe’s strongest.
Siemens Energy advanced after reporting record third-quarter results. Demand related to artificial-intelligence data centres and power-generation projects in the Middle East supported the German company’s performance.
The shares were initially up around 1.3% and extended their gain during the session. The company’s results reinforced expectations that rising electricity demand and data-centre investment will continue to benefit European power-equipment suppliers.
In London, retailer Next and miner Glencore helped the FTSE 100 remain positive. Retail and industrial companies also supported the broader European market.
Novo Nordisk and HSBC fall
Novo Nordisk dropped approximately 4% despite raising its annual sales and profit forecasts.
Investors focused on weaker-than-expected sales of the oral version of obesity treatment Wegovy and a setback involving CagriSema, the company’s next-generation weight-loss drug. Competition from Eli Lilly remains a central concern for the Danish pharmaceutical group.
The decline weighed on Copenhagen’s OMX C25 index and demonstrated that an improved financial outlook may not be sufficient when investors are more concerned about a company’s future product pipeline.
HSBC fell about 3.5% as investors continued to digest the bank’s latest results. The broader European banking sector declined approximately 0.9%, making it one of the weakest groups of the session.
Lower government-bond yields can place pressure on banks’ net interest margins, while uncertainty surrounding economic growth and credit quality remained in focus.
European luxury stocks also underperformed. LVMH declined, limiting the CAC 40’s progress as investors continued to question the strength of demand for high-end goods.
Oil rebounds after tanker attack
Energy shares gained about 0.6% as crude prices rebounded.
Brent crude moved back above $80 a barrel following a missile attack by Yemen’s Houthi movement on a Saudi oil tanker in the Red Sea. The incident renewed concerns about shipping security and potential supply disruptions.
The move followed more optimistic signals from diplomatic negotiations involving the United States and Iran. Those discussions had previously reduced fears of a prolonged interruption to traffic through the Strait of Hormuz.
The conflicting developments left investors balancing the possibility of diplomatic progress against the continuing risk of new attacks on energy infrastructure and commercial shipping.
Higher oil prices supported energy producers but created a less favourable background for airlines, transport companies and other fuel-intensive businesses.
Gold and miners attract buyers
Gold climbed to a one-month high as investors sought defensive assets and the dollar weakened.
The metal’s advance helped European mining companies, including Glencore and precious-metals producers. Lower bond yields also supported gold by reducing the opportunity cost of holding an asset that does not generate interest.
The combination of geopolitical uncertainty, changing interest-rate expectations and currency movements is likely to keep precious metals volatile.
What investors will watch next
European markets remain supported by improving corporate profits, but Wednesday’s mixed closing performance indicates that investors are becoming more selective.
The next sessions will be shaped by:
- Additional European and U.S. company results
- Developments in negotiations concerning Iran
- Oil traffic through the Strait of Hormuz
- European and U.S. bond yields
- Expectations for Federal Reserve and European Central Bank policy
- New economic data on employment, inflation and consumer demand
For Belgian investors, the BEL 20’s proximity to its record high increases the importance of results from its largest constituents. Sustained gains will probably require continued earnings growth from financial, healthcare and consumer companies rather than higher valuation multiples alone.
Brussels nevertheless ended Wednesday with a clear advantage over most neighbouring markets: the BEL 20 gained more than 1%, while the principal French, German, Dutch and eurozone indices finished close to unchanged.
Reuters European market report
Euronext BEL 20 market page
Market data are based on closing or latest available prices on August 5, 2026. Some quotations may be delayed. This article is for informational purposes and does not constitute investment advice.
